Full coverage· Health· Updated
Israeli Researchers Develop Highly Accurate Early Breast Cancer Blood Test
Israeli researchers have developed an experimental blood test that detects early-stage breast cancer with 95% accuracy for tumors under two centimeters. The test, which analyzes epigenetic markers, also predicts recurrence risk with 81% accuracy.
2 newsrooms · 2 languages · since
Plus
What happened
- 01An experimental blood test developed by Israeli researchers detects early breast cancer with 95% accuracy.
- 02The test analyzes epigenetic markers to identify aggressive cancer cells and predict recurrence risk.
- 03It achieved 81% accuracy in distinguishing between patients who experienced cancer recurrence and those who did not.
- 04The research was a collaboration between the Weizmann Institute of Science and Hebrew University.
- 05The findings were published in the prestigious scientific journal Nature.
- 06The test's accuracy is not affected by breast density, a limitation of mammograms.
Published in Nature, the study involved international collaboration and could lead to new therapies targeting cancer's epigenetic flexibility.
The Times of Israel publishes in English. The key points are summarized above. Read The Times of Israel’s full report from the link below.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- Centre2
- RightNone
- HarediNone
- ArabNone
How it broke
See which of the 2 newsrooms broke it, and who waited
